• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>AVP

AVP

  1. All
  2. Morningstar Articles
  3. 3rd Party
  1. Avanir Pharmaceuticals Receives Complete Response Letter (CRL) from FDA on AVP -825 NDA

    Avanir Pharmaceuticals Receives Complete Response Letter (CRL) from FDA on AVP -825 NDA

  2. Allot CloudTrends Report Finds CSPs are Leveraging the Experience of Cloud Applications like Microsoft Office 365 and Lync

    Allot CloudTrends Report Finds CSPs are Leveraging the Experience of Cloud Applications like Microsoft Office 365 and Lync

  3. Avcorp announces 2014 Third Quarter Financial Results

    Avcorp announces 2014 Third Quarter Financial Results

  4. OptiNose Announces Publication of Pivotal Phase III Results for Investigational Migraine Treatment Developed by OptiNose Using Bi-Directional™ Breath Powered™ Technology

    OptiNose Announces Publication of Pivotal Phase III Results for Investigational Migraine Treatment Developed by OptiNose Using Bi-Directional™ Breath Powered™ Technology

  5. Allot Communications Appoints Shmuel Arvatz as New Chief Financial Officer

    Allot Communications Appoints Shmuel Arvatz as New Chief Financial Officer

  6. Sell your Bonds and Gold and Buy Dividend Growth Stocks Before it is Too Late

    Disclaimer: The opinions in this document are for informational and educational purposes only and should not be construed as a recommendation to buy or sell the stocks mentioned or to solicit transactions or clients. Past performance of the companies discussed may not continue and the companies may ...

Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.